Along­side tiny da­ta drop, Cari­bou plans dose es­ca­la­tion for its first off-the-shelf CAR-T tri­al

In May, Cari­bou Bio­sciences shared im­pres­sive ear­ly da­ta on its first tri­al for an off-the-shelf CAR-T ther­a­py, dis­clos­ing that four of five pa­tients suf­fer­ing from …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER